Curious to see the emissions of the organizations you buy from or invest in?
Book a demo for a pilot project
Pharmanutra
Pharmaceutical Preparation ManufacturingItalyMIL: PHN.MI
Last verified 27 days agopharmanutra.it
Pharmanutra S.p.A., a leading name in the pharmaceutical preparation manufacturing industry, is headquartered in Italy and operates extensively across Europe and beyond. Founded in 2003, the company has established itself as a pioneer in the development of innovative nutritional supplements and medical devices, particularly those based on iron and mineral formulations.
Pharmanutra's core products, including the renowned SiderAL® line, are distinguished by their unique formulations that enhance bioavailability and absorption, setting them apart in a competitive market. With a commitment to research and development, the company has achieved significant milestones, including numerous patents and collaborations with healthcare professionals.
Recognised for its quality and efficacy, Pharmanutra continues to strengthen its market position, contributing to advancements in health and wellness through scientifically-backed solutions.
34
DitchCarbon score
-8 vs industry average
Pharmanutra’s score of 34 is lower than 46% of the industry. This can give you a sense of how well the company is doing compared to its peers.
Part of the Sustainability team at Pharmanutra?
- Control how your company's emission story is told
- Respond to customers efficiently
- See who's viewing your profile
Industry Intensity
Very Low
Pharmaceutical Preparation Manufacturing is among the least carbon-intensive industries
Industry performance
0.243
02025
The Pharmaceutical Preparation Manufacturing industry has increased its overall emissions by 132% since 0
Emissions trajectory 2020 – 2027
20202021202220232024202520262027
Reported emissions
Scope 1
•••kg CO₂e
Scope 2
•••kg CO₂e
Scope 3
•••kg CO₂e
Total reported
•••kg CO₂e
Scope 3 accounts for ••• of total emissions.
Pharmanutra's reported carbon emissions
Pharmanutra, an Italian pharmaceutical preparation manufacturer, reported its 2024 Scope 1 emissions as 220,000 kg CO2e and Scope 2 (market-based) emissions as 931,000 kg CO2e. In 2023, the company's Scope 1 emissions were approximately 229,000 kg CO2e, with Scope 2 (market-based) emissions around 271,000 kg CO2e. For 2022, Scope 1 emissions were about 199,000 kg CO2e and Scope 2 (market-based) emissions were approximately 58,000 kg CO2e. Pharmanutra has disclosed Scope 1 and Scope 2 emissions but has not yet reported Scope 3 emissions. The company currently has no specific emissions reduction targets or climate pledges.
Assessing Pharmanutra as a supplier or portfolio company?
- See verified emissions data for over 2 million organizations
- View emissions forecasts for Pharmanutra and the organizations you buy from or invest in
- Get PCAF data quality (DQ) scores, including for private organizations
Pharmanutra’s Climate Goals (2030 & 2050)
No climate goals have been disclosed for Pharmanutra yet.
Scope 3 top emissions categories
No scope 3 category breakdown has been disclosed yet.
Climate initiatives
Science Based Targets Initiative
See details
Not active
Carbon Disclosure Project
Sign in to view
Active
The Climate Pledge
See details
Not active
UN Global Compact Climate Champions initiative
See details
Not active
RE 100
See details
Not active
Climate Action 100
See details
Not active
Emissions comparison with industry peers
View similar organisationsCompanyCountryIndustryLast updatedScoreDetails
Pharmanutra27 days ago
34
Need this data for financed emissions?
PCAF scored Scope 1, 2 and 3 for 2M+ organizations, including private ones.
Usage policy
You’re welcome to quote or reference data from this page, but please include a visible link back to this URL. Bulk collection, resale, or redistribution of data from multiple profiles is not permitted.
See our License Agreement for more details.
Where does DitchCarbondata come from?
Discover our data-driven methodology for measuring corporate climate action and benchmarking against industry peers
Learn more